Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 403

1.

Oscillatory connectivity as a diagnostic marker of dementia due to Alzheimer's disease.

Musaeus CS, Engedal K, Høgh P, Jelic V, Mørup M, Naik M, Oeksengaard AR, Snaedal J, Wahlund LO, Waldemar G, Andersen BB.

Clin Neurophysiol. 2019 Oct;130(10):1889-1899. doi: 10.1016/j.clinph.2019.07.016. Epub 2019 Jul 29.

PMID:
31408790
2.

APOE and cortical superficial siderosis in CAA: Meta-analysis and potential mechanisms.

Charidimou A, Zonneveld HI, Shams S, Kantarci K, Shoamanesh A, Hilal S, Yates PA, Boulouis G, Na HK, Pasi M, Biffi A, Chai YL, Chong JR, Wahlund LO, Clifford JR, Chen C, Gurol ME, Goldstein JN, Na DL, Barkhof F, Seo SW, Rosand J, Greenberg SM, Viswanathan A.

Neurology. 2019 Jul 23;93(4):e358-e371. doi: 10.1212/WNL.0000000000007818. Epub 2019 Jun 26.

PMID:
31243071
3.

AVRA: Automatic visual ratings of atrophy from MRI images using recurrent convolutional neural networks.

Mårtensson G, Ferreira D, Cavallin L, Muehlboeck JS, Wahlund LO, Wang C, Westman E; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage Clin. 2019;23:101872. doi: 10.1016/j.nicl.2019.101872. Epub 2019 May 25.

4.

Inflammatory biomarkers in Alzheimer's disease plasma.

Morgan AR, Touchard S, Leckey C, O'Hagan C, Nevado-Holgado AJ; NIMA Consortium, Barkhof F, Bertram L, Blin O, Bos I, Dobricic V, Engelborghs S, Frisoni G, Frölich L, Gabel S, Johannsen P, Kettunen P, Kłoszewska I, Legido-Quigley C, Lleó A, Martinez-Lage P, Mecocci P, Meersmans K, Molinuevo JL, Peyratout G, Popp J, Richardson J, Sala I, Scheltens P, Streffer J, Soininen H, Tainta-Cuezva M, Teunissen C, Tsolaki M, Vandenberghe R, Visser PJ, Vos S, Wahlund LO, Wallin A, Westwood S, Zetterberg H, Lovestone S, Morgan BP; Annex: NIMA–Wellcome Trust Consortium for Neuroimmunology of Mood Disorders and Alzheimer's Disease.

Alzheimers Dement. 2019 Jun;15(6):776-787. doi: 10.1016/j.jalz.2019.03.007. Epub 2019 Apr 30.

5.

Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study.

Jernerén F, Cederholm T, Refsum H, Smith AD, Turner C, Palmblad J, Eriksdotter M, Hjorth E, Faxen-Irving G, Wahlund LO, Schultzberg M, Basun H, Freund-Levi Y.

J Alzheimers Dis. 2019;69(1):189-197. doi: 10.3233/JAD-181148.

PMID:
30958356
6.

Differential Associations of IL-4 With Hippocampal Subfields in Mild Cognitive Impairment and Alzheimer's Disease.

Boccardi V, Westman E, Pelini L, Lindberg O, Muehlboeck JS, Simmons A, Tarducci R, Floridi P, Chiarini P, Soininen H, Kloszewska I, Tsolaki M, Vellas B, Spenger C, Wahlund LO, Lovestone S, Mecocci P.

Front Aging Neurosci. 2019 Jan 17;10:439. doi: 10.3389/fnagi.2018.00439. eCollection 2018.

7.

Androgen deprivation therapy for prostate cancer and risk of dementia.

Robinson D, Garmo H, Van Hemelrijck M, Damber JE, Bratt O, Holmberg L, Wahlund LO, Stattin P, Adolfsson J.

BJU Int. 2019 Jul;124(1):87-92. doi: 10.1111/bju.14666. Epub 2019 Feb 6.

PMID:
30637900
8.

Brain myoinositol as a potential marker of amyloid-related pathology: A longitudinal study.

Voevodskaya O, Poulakis K, Sundgren P, van Westen D, Palmqvist S, Wahlund LO, Stomrud E, Hansson O, Westman E; Swedish BioFINDER Study Group.

Neurology. 2019 Jan 29;92(5):e395-e405. doi: 10.1212/WNL.0000000000006852. Epub 2019 Jan 4.

9.

A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortium.

Oppedal K, Ferreira D, Cavallin L, Lemstra AW, Ten Kate M, Padovani A, Rektorova I, Bonanni L, Wahlund LO, Engedal K, Nobili F, Kramberger M, Taylor JP, Hort J, Snædal J, Blanc F, Walker Z, Antonini A, Westman E, Aarsland D; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2019 Mar;15(3):400-409. doi: 10.1016/j.jalz.2018.09.011. Epub 2018 Nov 12.

PMID:
30439333
10.

The heterogeneity within Alzheimer's disease.

Ferreira D, Wahlund LO, Westman E.

Aging (Albany NY). 2018 Nov 14;10(11):3058-3060. doi: 10.18632/aging.101638. No abstract available.

11.

Default Mode Network Complexity and Cognitive Decline in Mild Alzheimer's Disease.

Grieder M, Wang DJJ, Dierks T, Wahlund LO, Jann K.

Front Neurosci. 2018 Oct 23;12:770. doi: 10.3389/fnins.2018.00770. eCollection 2018.

12.

EEG Theta Power Is an Early Marker of Cognitive Decline in Dementia due to Alzheimer's Disease.

Musaeus CS, Engedal K, Høgh P, Jelic V, Mørup M, Naik M, Oeksengaard AR, Snaedal J, Wahlund LO, Waldemar G, Andersen BB.

J Alzheimers Dis. 2018;64(4):1359-1371. doi: 10.3233/JAD-180300.

PMID:
29991135
13.

The contribution of small vessel disease to subtypes of Alzheimer's disease: a study on cerebrospinal fluid and imaging biomarkers.

Ferreira D, Shams S, Cavallin L, Viitanen M, Martola J, Granberg T, Shams M, Aspelin P, Kristoffersen-Wiberg M, Nordberg A, Wahlund LO, Westman E.

Neurobiol Aging. 2018 Oct;70:18-29. doi: 10.1016/j.neurobiolaging.2018.05.028. Epub 2018 May 30.

PMID:
29935417
14.

Heterogeneous patterns of brain atrophy in Alzheimer's disease.

Poulakis K, Pereira JB, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Wahlund LO, Westman E.

Neurobiol Aging. 2018 May;65:98-108. doi: 10.1016/j.neurobiolaging.2018.01.009. Epub 2018 Jan 31.

PMID:
29455029
15.

Cognitive medicine - a new approach in health care science.

Wallin A, Kettunen P, Johansson PM, Jonsdottir IH, Nilsson C, Nilsson M, Eckerström M, Nordlund A, Nyberg L, Sunnerhagen KS, Svensson J, Terzis B, Wahlund LO, Georg Kuhn H.

BMC Psychiatry. 2018 Feb 8;18(1):42. doi: 10.1186/s12888-018-1615-0.

16.

Perivascular Spaces in Old Age: Assessment, Distribution, and Correlation with White Matter Hyperintensities.

Laveskog A, Wang R, Bronge L, Wahlund LO, Qiu C.

AJNR Am J Neuroradiol. 2018 Jan;39(1):70-76. doi: 10.3174/ajnr.A5455. Epub 2017 Nov 23.

17.

Does Fatty Acid Composition in Subcutaneous Adipose Tissue Differ between Patients with Alzheimer's Disease and Cohabiting Proxies?

Faxen-Irving G, Falahati F, Basun H, Eriksdotter M, Vedin I, Wahlund LO, Schultzberg M, Hjorth E, Palmblad J, Cederholm T, Freund-Levi Y.

J Alzheimers Dis. 2018;61(2):515-519. doi: 10.3233/JAD-170359.

PMID:
29154271
18.

Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.

Reijs BLR, Ramakers IHGB, Elias-Sonnenschein L, Teunissen CE, Koel-Simmelink M, Tsolaki M, Wahlund LO, Waldemar G, Hausner L, Johannsen P, Vanderstichele H, Verhey F, Devanand DP, Visser PJ.

J Alzheimers Dis. 2017;60(3):1025-1034. doi: 10.3233/JAD-170564.

PMID:
28984603
19.

Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study.

Reijs BLR, Ramakers IHGB, Köhler S, Teunissen CE, Koel-Simmelink M, Nathan PJ, Tsolaki M, Wahlund LO, Waldemar G, Hausner L, Vandenberghe R, Johannsen P, Blackwell A, Vanderstichele H, Verhey F, Visser PJ.

J Alzheimers Dis. 2017;60(3):1119-1128. doi: 10.3233/JAD-160766.

PMID:
28984585
20.

Atrophy of the Posterior Subiculum Is Associated with Memory Impairment, Tau- and Aβ Pathology in Non-demented Individuals.

Lindberg O, Mårtensson G, Stomrud E, Palmqvist S, Wahlund LO, Westman E, Hansson O.

Front Aging Neurosci. 2017 Sep 20;9:306. doi: 10.3389/fnagi.2017.00306. eCollection 2017.

21.

Topography and Determinants of Magnetic Resonance Imaging (MRI)-Visible Perivascular Spaces in a Large Memory Clinic Cohort.

Shams S, Martola J, Charidimou A, Larvie M, Granberg T, Shams M, Kristoffersen-Wiberg M, Wahlund LO.

J Am Heart Assoc. 2017 Sep 22;6(9). pii: e006279. doi: 10.1161/JAHA.117.006279.

22.

Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid.

Falahati F, Ferreira D, Muehlboeck JS, Eriksdotter M, Simmons A, Wahlund LO, Westman E.

Neuroimage Clin. 2017 Aug 14;16:418-428. doi: 10.1016/j.nicl.2017.08.014. eCollection 2017.

23.

DHA-rich n-3 fatty acid supplementation decreases DNA methylation in blood leukocytes: the OmegAD study.

Karimi M, Vedin I, Freund Levi Y, Basun H, Faxén Irving G, Eriksdotter M, Wahlund LO, Schultzberg M, Hjorth E, Cederholm T, Palmblad J.

Am J Clin Nutr. 2017 Oct;106(4):1157-1165. doi: 10.3945/ajcn.117.155648. Epub 2017 Aug 30.

PMID:
28855224
24.

MRI of the Swallow Tail Sign: A Useful Marker in the Diagnosis of Lewy Body Dementia?

Shams S, Fällmar D, Schwarz S, Wahlund LO, van Westen D, Hansson O, Larsson EM, Haller S.

AJNR Am J Neuroradiol. 2017 Sep;38(9):1737-1741. doi: 10.3174/ajnr.A5274. Epub 2017 Jul 13.

25.

Physical activity level in people with age related white matter changes correlates to better motor performance, lower comorbidity and higher cognitive level.

Pettersson AF, Wahlund LO, Bronge L, Olsson E, Amberla K, Baezner H, Crisby M.

BMC Geriatr. 2017 Jul 12;17(1):142. doi: 10.1186/s12877-017-0535-z.

26.

Validity and reliability of Abbreviated Mental Test Score (AMTS) among older Iranian.

Foroughan M, Wahlund LO, Jafari Z, Rahgozar M, Farahani IG, Rashedi V.

Psychogeriatrics. 2017 Nov;17(6):460-465. doi: 10.1111/psyg.12276. Epub 2017 Jun 6.

PMID:
28589659
27.

Distinct subtypes of Alzheimer's disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications.

Ferreira D, Verhagen C, Hernández-Cabrera JA, Cavallin L, Guo CJ, Ekman U, Muehlboeck JS, Simmons A, Barroso J, Wahlund LO, Westman E.

Sci Rep. 2017 Apr 18;7:46263. doi: 10.1038/srep46263.

28.

The interactive effect of demographic and clinical factors on hippocampal volume: A multicohort study on 1958 cognitively normal individuals.

Ferreira D, Hansson O, Barroso J, Molina Y, Machado A, Hernández-Cabrera JA, Muehlboeck JS, Stomrud E, Nägga K, Lindberg O, Ames D, Kalpouzos G, Fratiglioni L, Bäckman L, Graff C, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Ahlström H, Lind L, Larsson EM, Wahlund LO, Simmons A, Westman E; the AddNeuroMed consortium, for the Alzheimer's Disease Neuroimaging Initiative (ADNI); Australian Imaging Biomarkers and Lifestyle Study of Ageing (AIBL) research group.

Hippocampus. 2017 Jun;27(6):653-667. doi: 10.1002/hipo.22721. Epub 2017 Apr 10.

PMID:
28394034
29.

Specific patterns of whole-brain structural covariance of the anterior and posterior hippocampus in young APOE ε4 carriers.

Stening E, Persson J, Eriksson E, Wahlund LO, Zetterberg H, Söderlund H.

Behav Brain Res. 2017 May 30;326:256-264. doi: 10.1016/j.bbr.2017.03.013. Epub 2017 Mar 9.

PMID:
28284953
30.

A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.

Khan W, Giampietro V, Banaschewski T, Barker GJ, Bokde AL, Büchel C, Conrod P, Flor H, Frouin V, Garavan H, Gowland P, Heinz A, Ittermann B, Lemaître H, Nees F, Paus T, Pausova Z, Rietschel M, Smolka MN, Ströhle A, Gallinat J, Vellas B, Soininen H, Kloszewska I, Tsolaki M, Mecocci P, Spenger C, Villemagne VL, Masters CL, Muehlboeck JS, Bäckman L, Fratiglioni L, Kalpouzos G, Wahlund LO, Schumann G, Lovestone S, Williams SC, Westman E, Simmons A; Alzheimer–s Disease Neuroimaging Initiative; AddNeuroMed Consortium, Australian, Imaging, Biomarkers, and Lifestyle Study Research Group; IMAGEN consortium.

J Alzheimers Dis. 2017;56(3):1159-1174. doi: 10.3233/JAD-161097.

31.

Predicting Cognitive Decline across Four Decades in Mutation Carriers and Non-carriers in Autosomal-Dominant Alzheimer's Disease.

Almkvist O, Rodriguez-Vieitez E, Thordardottir S, Amberla K, Axelman K, Basun H, Kinhult-Ståhlbom A, Lilius L, Remes A, Wahlund LO, Viitanen M, Lannfelt L, Graff C.

J Int Neuropsychol Soc. 2017 Mar;23(3):195-203. doi: 10.1017/S1355617716001028. Epub 2017 Jan 12.

PMID:
28079014
32.

Imaging biomarkers of dementia: recommended visual rating scales with teaching cases.

Wahlund LO, Westman E, van Westen D, Wallin A, Shams S, Cavallin L, Larsson EM; From the Imaging Cognitive Impairment Network (ICINET).

Insights Imaging. 2017 Feb;8(1):79-90. doi: 10.1007/s13244-016-0521-6. Epub 2016 Dec 21. Review.

33.

Reproducible segmentation of white matter hyperintensities using a new statistical definition.

Damangir S, Westman E, Simmons A, Vrenken H, Wahlund LO, Spulber G.

MAGMA. 2017 Jun;30(3):227-237. doi: 10.1007/s10334-016-0599-3. Epub 2016 Dec 9.

34.

The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease.

Li X, Westman E, Thordardottir S, Ståhlbom AK, Almkvist O, Blennow K, Wahlund LO, Graff C.

J Alzheimers Dis. 2017;56(1):327-334. doi: 10.3233/JAD-160730.

PMID:
27911308
35.

Diverging Progression of Network Disruption and Atrophy in Alzheimer's Disease and Semantic Dementia.

Andreotti J, Dierks T, Wahlund LO, Grieder M.

J Alzheimers Dis. 2017;55(3):981-993.

36.

Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors.

Rivero-Santana A, Ferreira D, Perestelo-Pérez L, Westman E, Wahlund LO, Sarría A, Serrano-Aguilar P.

J Alzheimers Dis. 2017;55(2):625-644. Review.

PMID:
27716663
37.

Electroencephalography Is a Good Complement to Currently Established Dementia Biomarkers.

Ferreira D, Jelic V, Cavallin L, Oeksengaard AR, Snaedal J, Høgh P, Andersen BB, Naik M, Engedal K, Westman E, Wahlund LO.

Dement Geriatr Cogn Disord. 2016;42(1-2):80-92. doi: 10.1159/000448394. Epub 2016 Sep 6.

PMID:
27595479
38.

Cortical superficial siderosis: Prevalence and biomarker profile in a memory clinic population.

Shams S, Martola J, Charidimou A, Cavallin L, Granberg T, Shams M, Forslin Y, Aspelin P, Kristoffersen-Wiberg M, Wahlund LO.

Neurology. 2016 Sep 13;87(11):1110-7. doi: 10.1212/WNL.0000000000003088. Epub 2016 Aug 17.

39.

Mixed brain lesions mediate the association between cardiovascular risk burden and cognitive decline in old age: A population-based study.

Wang R, Fratiglioni L, Kalpouzos G, Lövdén M, Laukka EJ, Bronge L, Wahlund LO, Bäckman L, Qiu C.

Alzheimers Dement. 2017 Mar;13(3):247-256. doi: 10.1016/j.jalz.2016.06.2363. Epub 2016 Aug 10.

PMID:
27521789
40.

Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device.

Eyjolfsdottir H, Eriksdotter M, Linderoth B, Lind G, Juliusson B, Kusk P, Almkvist O, Andreasen N, Blennow K, Ferreira D, Westman E, Nennesmo I, Karami A, Darreh-Shori T, Kadir A, Nordberg A, Sundström E, Wahlund LO, Wall A, Wiberg M, Winblad B, Seiger Å, Wahlberg L, Almqvist P.

Alzheimers Res Ther. 2016 Jul 7;8(1):30. doi: 10.1186/s13195-016-0195-9.

41.

Cerebral microbleeds topography and cerebrospinal fluid biomarkers in cognitive impairment.

Shams S, Granberg T, Martola J, Charidimou A, Li X, Shams M, Fereshtehnejad SM, Cavallin L, Aspelin P, Wiberg-Kristoffersen M, Wahlund LO.

J Cereb Blood Flow Metab. 2017 Mar;37(3):1006-1013. doi: 10.1177/0271678X16649401. Epub 2016 Jul 21.

42.

Disrupted Network Topology in Patients with Stable and Progressive Mild Cognitive Impairment and Alzheimer's Disease.

Pereira JB, Mijalkov M, Kakaei E, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, Spenger C, Lovestone S, Simmons A, Wahlund LO, Volpe G, Westman E.

Cereb Cortex. 2016 Aug;26(8):3476-3493. doi: 10.1093/cercor/bhw128. Epub 2016 May 13.

43.

Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.

Voevodskaya O, Sundgren PC, Strandberg O, Zetterberg H, Minthon L, Blennow K, Wahlund LO, Westman E, Hansson O; Swedish BioFINDER study group.

Neurology. 2016 May 10;86(19):1754-61. doi: 10.1212/WNL.0000000000002672. Epub 2016 Apr 15.

44.

Discovering EEG resting state alterations of semantic dementia.

Grieder M, Koenig T, Kinoshita T, Utsunomiya K, Wahlund LO, Dierks T, Nishida K.

Clin Neurophysiol. 2016 May;127(5):2175-81. doi: 10.1016/j.clinph.2016.01.025. Epub 2016 Feb 15.

PMID:
27072087
45.

Measuring Global Brain Atrophy with the Brain Volume/Cerebrospinal Fluid Index: Normative Values, Cut-Offs and Clinical Associations.

Orellana C, Ferreira D, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Wahlund LO, Westman E; AddNeuronMed consortium and for the Alzheimer''s Disease Neuroimaging Initiative.

Neurodegener Dis. 2016;16(1-2):77-86. doi: 10.1159/000442443. Epub 2015 Dec 19.

PMID:
26726737
46.

The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice.

Cacciottolo M, Christensen A, Moser A, Liu J, Pike CJ, Smith C, LaDu MJ, Sullivan PM, Morgan TE, Dolzhenko E, Charidimou A, Wahlund LO, Wiberg MK, Shams S, Chiang GC; Alzheimer's Disease Neuroimaging Initiative, Finch CE.

Neurobiol Aging. 2016 Jan;37:47-57. doi: 10.1016/j.neurobiolaging.2015.10.010. Epub 2015 Oct 19.

47.

Cerebrospinal fluid profiles with increasing number of cerebral microbleeds in a continuum of cognitive impairment.

Shams S, Granberg T, Martola J, Li X, Shams M, Fereshtehnejad SM, Cavallin L, Aspelin P, Kristoffersen-Wiberg M, Wahlund LO.

J Cereb Blood Flow Metab. 2016 Mar;36(3):621-8. doi: 10.1177/0271678X15606141. Epub 2015 Sep 30.

48.

Cerebral microbleeds as a biomarker in Alzheimer's disease? A review in the field.

Shams S, Wahlund LO.

Biomark Med. 2016;10(1):9-18. doi: 10.2217/bmm.15.101. Epub 2015 Dec 7. Review.

PMID:
26641942
49.

Apolipoprotein E ϵ4 is positively related to spatial performance but unrelated to hippocampal volume in healthy young adults.

Stening E, Persson J, Eriksson E, Wahlund LO, Zetterberg H, Söderlund H.

Behav Brain Res. 2016 Feb 15;299:11-8. doi: 10.1016/j.bbr.2015.11.006. Epub 2015 Nov 12.

PMID:
26581118
50.

Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4, CSF biomarkers and cognition.

Ferreira D, Cavallin L, Granberg T, Lindberg O, Aguilar C, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Wahlund LO, Westman E; AddNeuroMed consortium and for the Alzheimer’s Disease Neuroimaging Initiative*.

Eur Radiol. 2016 Aug;26(8):2597-610. doi: 10.1007/s00330-015-4101-9. Epub 2015 Nov 11.

PMID:
26560730

Supplemental Content

Loading ...
Support Center